ECOG-ACRIN E2108

Primary Category:

Treatment Protocols

Disease Category:

Breast, Breast Metastatic, Breast Neoadjuvant

Status:

Closed

A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer

 

E2108 is approaching its accrual goal. Therefore, this study closed to accrual effective July 23, 2015 at 5:00 p.m. EDT for Step 1 registrations.  Patients already registered to Step 1 may continue the process to Step 2 randomization, however no new Step 1 registrations will be permitted after this date.

NCT#01242800

Leave a Reply